TURKEL CATHERINE C. 4
4 · Lexaria Bioscience Corp. · Filed Oct 13, 2022
Insider Transaction Report
Form 4
TURKEL CATHERINE C.
Director
Transactions
- Award
Stock Options
2022-10-12+1,600→ 5,000 totalExercise: $1.96From: 2022-10-12Exp: 2027-10-12→ Common Shares (1,600 underlying)
Holdings
- 3,400
Stock Options
Exercise: $3.04From: 2022-09-02Exp: 2027-09-02→ Common Shares (3,400 underlying)